Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Correlation between vancomycin AUC and trough levels
2015-003171-29Phase 4Terminated
- Sponsor
- University Hospital Tübingen
- Start
- Nov 2015
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of vancomycin in bacterial disease, sponsored by University Hospital Tübingen. Started Nov 2015; status: terminated.
02
Drugs
vancomycin
03
Conditions
bacterial disease
Beyond the preview
Go deeper on 2015-003171-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003171-29.